MPR Weekly Dose Podcast: Episode 7

from MPR Weekly Dose · host MPR Weekly Dose

This week: New Invokana approval; More ranitidine recalls lead CVS to suspend all sales; FDA has identifies 11 serious cybersecurity vulnerabilities that could affect medical devices and hospital networks; Entresto indication expanded; and COPD investigate treatment is rejected.

Episode metadata supplied by the publisher feed · Published Oct 4, 2019

Embed this episode

Attribution link and audio player

Ready to play

MPR Weekly Dose Podcast: Episode 7

0:00 8:06

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MPR Weekly Dose?

This episode is 8 minutes long.

When was this MPR Weekly Dose episode published?

This episode was published on October 4, 2019.

Can I download this MPR Weekly Dose episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!